Insider Buying: AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Buys 60,000 Shares of Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett purchased 60,000 shares of the firm’s stock in a transaction on Tuesday, April 7th. The shares were purchased at an average cost of $2.93 per share, with a total value of $175,800.00. Following the completion of the transaction, the insider owned 6,993,761 shares of the company’s stock, valued at approximately $20,491,719.73. The trade was a 0.87% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Friday, April 3rd, Jorey Chernett purchased 90,000 shares of AirSculpt Technologies stock. The shares were purchased at an average cost of $2.82 per share, with a total value of $253,800.00.
• On Monday, March 23rd, Jorey Chernett purchased 50,000 shares of AirSculpt Technologies stock. The shares were purchased at an average cost of $2.91 per share, with a total value of $145,500.00.
• On Friday, March 20th, Jorey Chernett purchased 40,000 shares of AirSculpt Technologies stock. The shares were purchased at an average cost of $2.77 per share, with a total value of $110,800.00.
• On Thursday, March 19th, Jorey Chernett purchased 77,702 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.64 per share, for a total transaction of $205,133.28.
• On Tuesday, March 17th, Jorey Chernett purchased 83,000 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.56 per share, for a total transaction of $212,480.00.
• On Monday, March 16th, Jorey Chernett purchased 105,848 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.43 per share, for a total transaction of $257,210.64.
• On Wednesday, March 11th, Jorey Chernett purchased 88,000 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.15 per share, for a total transaction of $189,200.00.
• On Friday, March 6th, Jorey Chernett purchased 45,600 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.00 per share, for a total transaction of $91,200.00.
• On Wednesday, March 4th, Jorey Chernett purchased 30,000 shares of AirSculpt Technologies stock. The stock was acquired at an average price of $1.87 per share, with a total value of $56,100.00.
• On Tuesday, March 3rd, Jorey Chernett purchased 80,000 shares of AirSculpt Technologies stock. The stock was acquired at an average price of $1.71 per share, with a total value of $136,800.00.

AirSculpt Technologies Stock Down 1.2%

AirSculpt Technologies stock traded down $0.04 during midday trading on Wednesday, reaching $2.90. The company’s stock had a trading volume of 291,744 shares, compared to its average volume of 2,663,585. The stock’s 50-day simple moving average is $2.34 and its 200-day simple moving average is $4.29. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.51 and a quick ratio of 0.51. AirSculpt Technologies, Inc. has a 52-week low of $1.51 and a 52-week high of $12.00. The stock has a market capitalization of $204.88 million, a P/E ratio of -15.24 and a beta of 2.22.

AirSculpt Technologies (NASDAQ:AIRS) last released its quarterly earnings results on Tuesday, March 31st. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.05. The company had revenue of $33.44 million during the quarter, compared to analysts’ expectations of $34.93 million. AirSculpt Technologies had a negative return on equity of 14.30% and a negative net margin of 11.41%.The firm’s revenue was down 14.8% compared to the same quarter last year. During the same period last year, the business posted ($0.09) earnings per share. On average, sell-side analysts expect that AirSculpt Technologies, Inc. will post -0.01 EPS for the current year.

Institutional Investors Weigh In On AirSculpt Technologies

Large investors have recently bought and sold shares of the company. BNP Paribas Financial Markets boosted its position in AirSculpt Technologies by 239.5% in the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock valued at $48,000 after buying an additional 4,199 shares during the last quarter. Intech Investment Management LLC purchased a new position in shares of AirSculpt Technologies during the third quarter worth $80,000. Brevan Howard Capital Management LP purchased a new position in shares of AirSculpt Technologies during the third quarter worth $83,000. Jane Street Group LLC purchased a new position in shares of AirSculpt Technologies during the second quarter worth $60,000. Finally, Creative Planning raised its holdings in shares of AirSculpt Technologies by 32.2% during the second quarter. Creative Planning now owns 13,225 shares of the company’s stock worth $64,000 after purchasing an additional 3,224 shares during the last quarter. Hedge funds and other institutional investors own 91.54% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of AirSculpt Technologies in a research report on Monday, December 29th. Wall Street Zen upgraded AirSculpt Technologies from a “sell” rating to a “hold” rating in a research note on Sunday. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average target price of $6.00.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.